Detection of Mycobacterium tuberculosis using Gene Xpert-MTB/RIF assay among tuberculosis suspected patients at Mizan-Tepi university teaching hospital, southwest Ethiopia: An institution based cross-sectional study

Abstract

Background Consistently deciding its current extent and chance elements of tuberculosis (TB) in all levels of clinical settings contributes to the anticipation and control exertion of the disease. In Ethiopia, updated information is still needed at every healthcare level and in different risk groups to monitor the national program’s performance, which aims to attain the 2035 goal. Hence, this study aimed to generate additional evidence data on the magnitude of Mycobacterium tuberculosis using the Gene Xpert assay among TB-suspected patients at Mizan-Tepi university teaching hospital, southwest Ethiopia. Methods A cross-sectional descriptive study was conducted from June to September 30, 2021. The required socio-demographic and other risk factor data were collected from a total of 422 suspected TB patients using a structured questionnaire. Approximately 392 pulmonary and 30 extra-pulmonary samples were collected and examined using the Gene Xpert-MTB/RIF assay. The statistical package for social sciences (SPSS) version 25 software was used to analyze the data. Results In this study, Mycobacterium tuberculosis was detected in 12.5% (49/392) of pulmonary samples and 13.3% (4/30) of extra-pulmonary samples, giving an overall TB positivity of 12.6% (53/422). Rifampicin-resistant M. tuberculosis was detected in 3/53 (5.7%). Male sex (AOR: 2.54; 95% CI: 1.210, 5.354), previous contact (AOR: 4.25; 95% CI: 1.790, 10.092), smoking cigarette (AOR: 4.708; 95% CI: 1.004, 22.081), being HIV-positive (AOR: 4.27; 95% CI: 1.606, 11.344), and malnutrition (AOR: 3.55; 95% CI: 1.175, 10.747) were all significantly associated with M. tuberculosis detection using the GeneXpert MTB/RIF assay. Conclusion The overall frequency of M. tuberculosis in this study was still significant in different risk groups, despite the proposed strategies, which aimed to reduce TB prevalence to as low as 10 per 100,000 populations by 2035. Early case detection with better diagnostic tools and public health measures are important prevention and control strategies to meet the proposed target and reduce the burden of TB in the country.

Trend of pulmonary tuberculosis and rifampicin-resistance among tuberculosis presumptive patients in Central Tigray, Ethiopia; 2018 -2023: a six-year retrospective study

“…In the present study, the overall magnitude of PTB was 11.7%, which is comparable to previously reported results from other parts of Ethiopia: Tigray (9.9%) [ 11 ], Eastern Amhara (11%) [ 15 ], Central Ethiopia (11.2%) [ 25 ], Addis Ababa (13.5%) [ 26 ], Mizan Tepi (12.6%) [ 27 ], Debre Brhan (13%) [ 28 ] and Northwest Ethiopia (14.6%) [ 29 ]. However, the current results were lower than previous findings conducted in Tigray (21%) [ 30 ], (24.3%) [ 21 ], Wolkite town (27.4%) [ 31 ], Awi Zone (18.7%) [ 32 ], Bahir Dar (21.7%) [ 33 ], Gondar (24.6%) [ 34 ], Bale (40.4%) [ 35 ], Tepi (58.6%) [ 36 ], Harar Town (61.2%) [ 10 ], Debre Markos (23.2%) [ 37 ] Nigeria (22.9%) [ 38 ], (27.5%) [ 39 ] and China (47.5%) [ 30 ].…”